First 2024 GaBI Journal issue highlights

Author(s): Robin Thorpe, PhD, FRCPath

It was with great pleasure that I assumed the role of Editor-in-Chief (EiC) of GaBI Journal in January of this year. Taking over the helm from Professor Philip D Walson is a considerable challenge; Phil’s excellent, thorough example will be very difficult to follow. My experience is restricted largely to biosimilars with which I have […]

Read more →